Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Third Quarter 2021 Net Revenues Increased 35% to $106.8 Million Year-Over-Year with Adjusted EBITDA Up 27% Year-Over-Year to $24.5 Million First Nine Months Net Revenues Increased 33% to $283.2...
La empresa combinada comenzará a cotizar en el Nasdaq Global Market® con las denominaciones "PROC" y "PROCW" el 30 de septiembre de 2021. Con unos 160 millones de dólares de ingresos brutos...
Empresa combinada iniciará comercialização no mercado global Nasdaq® com os códigos "PROC" e "PROCW" em 30 de setembro de 2021 Aproximadamente US$ 160 milhões de receitas brutas posicionam...
Combined Company to Begin Trading on the Nasdaq Global Market® Under “PROC” and “PROCW” On September 30, 2021 Approximately $160 Million of Gross Proceeds Strategically Positions Procaps, a...
Union Acquisition Corp. II (“LATN”) Shareholders Approve the Proposed Business Combination with Procaps Group and the Parties Agree to Close by September 30, 2021 Following the Closing of the...
Strong Financial Performance Enables Procaps Group to Launch Private Placement of Senior Notes to Refinance Existing Debt with New Institutional Investors Utilizing a Lower Cost of Capital &...
Extraordinary General Meeting of Union Acquisition Corp. II (“LATN”) Shareholders to Approve the Proposed Business Combination with Procaps Group Will be Held on September 22, 2021, at 9:00 a.m...
Procaps Group, a leading integrated international healthcare and pharmaceutical company, announced that in conjunction with Procaps Group’s recent virtual analyst day and second quarter 2021...
Senior Financial Executive (Previously CFO of CFR Pharmaceuticals) Brings 25 Years of Financial and Operational Experience to Lead Procaps Global Rollout and M&A Initiatives Procaps Group...
Second Quarter 2021 Net Revenues Increased 35% to $97 Million Year-Over-Year with Adjusted EBITDA Up 28% Year-Over-Year Company Reaffirms Revenue and Adjusted EBITDA Growth Trajectory for Full...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
